Oura's IPO Filing Reveals a Health Data Platform, Not Just a Wearables Company
核心洞察
Oura (搜索) posted slightly over $1.2 billion in total revenue for the nine months ending June 30, up 74% year over year, with net income growing from roughly $1.5 million to nearly $60.8 million.
The company sold 3.1 million rings and reached 5 million paying members, with membership revenue soaring 122% year over year at an 89% gross margin.
Oura (搜索) has compiled 42 billion hours of biometric data and leverages artificial intelligence to deliver predictive insights across sleep, activity, heart health, metabolic health, and women's health.
Oura (搜索), the Finnish health technology company behind the self-proclaimed "world's smallest smart ring," is preparing for an initial public offering as soon as this month, with reports indicating the company could seek a valuation exceeding $11 billion — and potentially as high as $16 billion. The company's recently released registration statement reveals a business that has transformed well beyond its hardware origins into a health analytics and data platform.
From Sleep Tracker to Health Data Platform
Oura (搜索)'s smart ring delivers more than 50 metrics and predictive insights into an individual's health. In the company's third fiscal quarter, paid members wore the ring for a median time of roughly 23 hours per day. The physical ring sells for $349 to $499, with members paying a $5.99 monthly subscription fee.
The company's transformation is underscored by its data assets. Oura (搜索) has compiled 42 billion hours of biometric data, which is not only personal data but also updated essentially in real time. The company leverages artificial intelligence to transform this data into predictive insights that members interact with on the Oura platform, receiving recommendations on sleep, activity, readiness, stress, heart health, metabolic health, and women's health.
Oura (搜索)'s platform also allows partners to connect via its API-first architecture and leverage Oura's insights to deliver additional clinical, physiological, and contextual data.
Strong Financial Performance
For the nine months ending June 30, Oura (搜索) posted slightly over $1.2 billion of total revenue, up 74% from the same period ending June 30 of 2025. Net income during this time grew from roughly $1.5 million to nearly $60.8 million — a rarity among IPOs these days, which the company describes as fast and profitable growth.
During the same nine-month period, Oura (搜索) sold 3.1 million rings and had 5 million paying members. While hardware revenue still accounted for 80% of total revenue, membership revenue soared 122% year over year. Member revenue generated an incredibly strong 89% gross margin, reflecting the high-margin, recurring nature of the subscription business.
Expanding Market Opportunities
Oura (搜索)'s registration statement states that the company believes its opportunities extend beyond the wearables market. Further cited opportunities include nutritional insights and guidance, conception planning and fertility insights, blood testing and analysis, and therapy and medication monitoring.
These opportunities fall into formal markets defined as fitness trackers, health and wellness coaching, selected digital care management applications, digital therapeutics, and selected connected biosensor categories, which collectively have a serviceable addressable market exceeding $90 billion in 2026, according to Statista.
Medical Ambitions and Clinical Positioning
The company has secured new partnerships with healthcare systems, expanded its FDA-cleared features, and invested heavily in AI-driven illness detection, cardiovascular health monitoring, and metabolic insights. Its recent acquisitions and research collaborations have positioned the ring as a clinical-grade tool, not just a wellness accessory.
Many believe AI will have a transformational impact on the healthcare space, and the fact that Oura (搜索) has already built a database of millions of members positions the company well to capitalize on this trend.
Valuation and Market Context
If Oura (搜索) hits its reported target, it would mark a notable ascent for a company valued at $5.2 billion after its $200 million Series D round in December 2024. A $16 billion-plus valuation would represent a more than 3x jump in under two years, a rare feat in a late-stage private market that has been largely cautious since 2022.
Analysts point out that public market comparables like Garmin (搜索) and Apple (搜索) trade at far more conservative revenue multiples for their wearables businesses. Oura (搜索) is expected to pitch itself not as a gadget maker, but as a health data platform, with investors buying recurring revenue, medical-grade data, and a foothold in the personalized health market.
Investors should keep in mind that not all outstanding shares are typically issued in an IPO. Many employees and insiders who obtained shares when the company was private are typically subject to lock-up agreements and cannot sell their shares for up to six months or more, meaning an IPO can rise at the beginning only to see the stock sell off later when more shares flood the market.